5 Key Takeaways
-
1
A meta-analysis revealed significant disparities in the prevalence of major retinal diseases by race, sex, and geography in the United States.
-
2
The age-standardized prevalence per 100,000 people was 5,677 for AMD, 2,710 for DR, 317 for DME, and 214 for RVO, with higher rates in males.
-
3
Approximately 21.9 million patients aged 40 and older had AMD in 2022, with 10 million affected by DR, 1.1 million by DME, and 0.9 million by RVO.
-
4
Prevalence rates varied significantly across racial groups, with AMD being 1.7 times higher in White patients compared to Black patients.
-
5
The study highlighted a substantial healthcare burden from retinal diseases, with estimated annual payer costs reaching $13.41 billion for AMD alone.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.